Ignite Creation Date:
2025-12-24 @ 10:37 PM
Ignite Modification Date:
2025-12-31 @ 1:41 PM
Study NCT ID:
NCT04217135
Status:
UNKNOWN
Last Update Posted:
2022-01-06
First Post:
2019-12-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation
Sponsor:
Kaohsiung Veterans General Hospital.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2019-12-29
First Submit QC Date:
None
Study First Post Date:
2020-01-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-04
Last Update Post Date:
2022-01-06
Last Update Post Date Type:
ACTUAL